4Filed Aug 11, 8:00 PM ET
Zevra Therapeutics Director Corey Watton Exercises Options, Sells 12,300 Shares
$ZVRA · ZEVRA THERAPEUTICS, INC.Research Summary
AI-generated summary of this SEC filing
Zevra Therapeutics Director Corey Watton Exercises Options, Sells 12,300 Shares
What Happened
Corey Michael Watton, a director of Zevra Therapeutics (ZVRA), exercised options to acquire 12,300 shares at $4.97 per share (cost $61,131) and then sold those 12,300 shares in the open market on Aug 10, 2026 for weighted‑average proceeds of $11.25 per share (≈ $138,377). The filing also shows the derivative (the option) was disposed at $0, reflecting conversion of the option into shares. Net cash proceeds from the trade were approximately $77,246 before taxes and fees. This sequence is effectively an exercise-and-sell (cashless) transaction rather than an outright open‑market purchase for investment.
Key Details
- Transaction date: August 10, 2026. Form 4 filed August 12, 2026 (timely within the 2‑business‑day window).
- Option exercise: 12,300 shares acquired at $4.97 each — total cost $61,131 (Transaction code M).
- Open‑market sale: 12,300 shares sold at a weighted average price of $11.25 — total proceeds ≈ $138,377 (Transaction code S). Footnote: sale prices ranged from $11.23 to $11.31; $11.25 is the weighted average.
- Derivative disposition: 12,300 option units reported disposed at $0, indicating conversion of the option into shares (footnote notes the underlying option was fully vested; grant date May 3, 2023).
- Shares owned after the transaction: not specified in the provided filing.
- No 10b5‑1 plan, gift, or tax‑withholding details disclosed in the supplied information.
Context
- This is a common pattern where an insider exercises vested options and immediately sells the resulting shares to realize gains (often called a cashless exercise or exercise-and-sell). It does not necessarily indicate a change in the insider’s view of the company—it's a liquidity event tied to option vesting.
- Purchases (insider buys) are generally considered more informative about confidence; here the material action for investors is the sale of shares after exercising options.
- The filing appears timely; the sale was executed in multiple trades (prices $11.23–$11.31).